Literature DB >> 28600015

Reoperation for Recurrent Glioblastoma Multiforme.

Adam M Robin1, Ian Lee2, Steven N Kalkanis3.   

Abstract

The role of reoperation for glioblastoma multiforme (GBM) recurrence is currently unknown. However, multiple studies have indicated that survival and quality of life are improved with a repeat operation at the time of disease recurrence. Prognosis is likely interdependent on several factors, including age, functional status, initial resection status, disease location, and surgical efficacy. However, there are significant data indicating no survival benefit for reoperation. This comprehensive literature review considering the controversial question of whether to operate for progressive or recurrent GBM seeks to evaluate the current available evidence and report on its conclusions.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Extent of resection; Glioblastoma multiforme; Recurrence; Reoperation; Resection; Survival

Mesh:

Year:  2017        PMID: 28600015     DOI: 10.1016/j.nec.2017.02.007

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  12 in total

1.  Diffusion Magnetic Resonance Imaging Phenotypes Predict Overall Survival Benefit From Bevacizumab or Surgery in Recurrent Glioblastoma With Large Tumor Burden.

Authors:  Kunal S Patel; Richard G Everson; Jingwen Yao; Catalina Raymond; Jodi Goldman; Jacob Schlossman; Joseph Tsung; Caleb Tan; Whitney B Pope; Matthew S Ji; Nhung T Nguyen; Albert Lai; Phioanh L Nghiemphu; Linda M Liau; Timothy F Cloughesy; Benjamin M Ellingson
Journal:  Neurosurgery       Date:  2020-10-15       Impact factor: 4.654

Review 2.  From imaging to biology of glioblastoma: new clinical oncology perspectives to the problem of local recurrence.

Authors:  A Zygogianni; M Protopapa; A Kougioumtzopoulou; F Simopoulou; S Nikoloudi; V Kouloulias
Journal:  Clin Transl Oncol       Date:  2018-01-15       Impact factor: 3.405

Review 3.  Shared decision making in high-grade glioma patients-a systematic review.

Authors:  Helle Sorensen von Essen; Karin Piil; Karina Dahl Steffensen; Frantz Rom Poulsen
Journal:  Neurooncol Pract       Date:  2020-07-24

Review 4.  Sonodynamic Therapy for Gliomas. Perspectives and Prospects of Selective Sonosensitization of Glioma Cells.

Authors:  Krzysztof Bilmin; Tamara Kujawska; Paweł Grieb
Journal:  Cells       Date:  2019-11-13       Impact factor: 6.600

5.  Reoperation for recurrent glioblastomas: What to expect?

Authors:  Iuri Santana Neville; Alexandra Gomes Dos Santos; Cesar Cimonari Almeida; Leonardo Bilich Abaurre; Samia Yasin Wayhs; Olavo Feher; Manoel Jacobsen Teixeira; Guilherme Lepski
Journal:  Surg Neurol Int       Date:  2021-02-03

6.  CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment.

Authors:  Mathieu Seyfrid; William Thomas Maich; Vaseem Muhammad Shaikh; Nazanin Tatari; Deepak Upreti; Deween Piyasena; Minomi Subapanditha; Neil Savage; Dillon McKenna; Nicholas Mikolajewicz; Hong Han; Chirayu Chokshi; Laura Kuhlmann; Amanda Khoo; Sabra Khalid Salim; Blessing Archibong-Bassey; William Gwynne; Kevin Brown; Nadeem Murtaza; David Bakhshinyan; Parvez Vora; Chitra Venugopal; Jason Moffat; Thomas Kislinger; Sheila Singh
Journal:  J Immunother Cancer       Date:  2022-01       Impact factor: 13.751

7.  Decisional needs of patients with recurrent high-grade glioma and their families.

Authors:  Helle Sorensen von Essen; Dawn Stacey; Karina Dahl Steffensen; Rikke Guldager; Frantz Rom Poulsen; Karin Piil
Journal:  Neurooncol Pract       Date:  2022-06-11

8.  Intracranial Sonodynamic Therapy With 5-Aminolevulinic Acid and Sodium Fluorescein: Safety Study in a Porcine Model.

Authors:  Luca Raspagliesi; Antonio D'Ammando; Matteo Gionso; Natasha D Sheybani; Maria-Beatriz Lopes; David Moore; Steven Allen; Jeremy Gatesman; Edoardo Porto; Kelsie Timbie; Andrea Franzini; Francesco Di Meco; Jason Sheehan; Zhiyuan Xu; Francesco Prada
Journal:  Front Oncol       Date:  2021-06-21       Impact factor: 6.244

9.  A novel three-dimensional template combined with MR-guided 125I brachytherapy for recurrent glioblastoma.

Authors:  Xiangmeng He; Ming Liu; Menglong Zhang; Roberto Blanco Sequeiros; Yujun Xu; Ligang Wang; Chao Liu; Qingwen Wang; Kai Zhang; Chengli Li
Journal:  Radiat Oncol       Date:  2020-06-08       Impact factor: 3.481

10.  The Impact of Surgery on the Survival of Patients with Recurrent Glioblastoma.

Authors:  Oumar Sacko; Alexandra Benouaich-Amiel; Pierre Brandicourt; Mahamadou Niaré; Saloua Charni; Clarissa Cavandoli; David Brauge; Isabelle Catalaa; Adam Brenner; Elizabeth Cohen-Jonathan Moyal; Franck-Emmanuel Roux
Journal:  Asian J Neurosurg       Date:  2021-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.